AllianceBernstein
PLXP

AllianceBernstein’s PLx Pharma Inc. Common Stock PLXP Stock Holding History

AllianceBernstein’s Portfolio PLXP Stock Details PLXP Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2015
Q2 		– Sell
-250
Closed -$27K – 3328
2015
Q1 		$27K Buy
+250
New +$25.6K ﹤0.01% 3221

Other funds holding PLXP

KCM
Kingdon Capital Management New York $911M AUM 51.11% 1-Year Est. Return
TCP
Tourbillon Capital Partners New York $6.26M AUM 42.29% 1-Year Est. Return
BC
Broadfin Capital New York $747M AUM 100.56% 1-Year Est. Return
TCM
Timpani Capital Management Milwaukee, Wisconsin $209M AUM 62.15% 1-Year Est. Return
LSVM
Lone Star Value Management Old Greenwich, Connecticut $52.7M AUM 30.18% 1-Year Est. Return
Alyeska Investment Group
Alyeska Investment Group Chicago, Illinois $35.4B AUM 33.54% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
6CM
683 Capital Management New York $1.92B AUM 85.52% 1-Year Est. Return
AAP
Ardsley Advisory Partners Stamford, Connecticut $960M AUM 207.76% 1-Year Est. Return
Millennium Management
Millennium Management New York $240B AUM 35.51% 1-Year Est. Return

AllianceBernstein's PLXP Position: Q2 2015 in Review

AllianceBernstein sold out of PLx Pharma Inc. Common Stock (PLXP) in Q2 2015, closing a stake of 250 shares — an estimated $27K sold.

AllianceBernstein first reported a position in PLXP in Q1 2015 and held it in 1 quarter. The position peaked at $27K in Q1 2015. 27 funds tracked by Wall St. Rank hold PLXP as of Q2 2015.

  • AllianceBernstein reported no remaining PLx Pharma Inc. Common Stock position as of Q2 2015 after selling out during the quarter.
  • AllianceBernstein sold 250 PLx Pharma Inc. Common Stock shares in Q2 2015, an estimated $27K.
  • AllianceBernstein first reported a position in PLx Pharma Inc. Common Stock in Q1 2015 and held it in 1 quarter.
  • AllianceBernstein's PLx Pharma Inc. Common Stock position peaked at $27K in Q1 2015.
  • 27 funds tracked by Wall St. Rank held PLx Pharma Inc. Common Stock as of Q2 2015.

Based on AllianceBernstein's 13F filing for Q2 2015, filed 14 Aug 2015.